New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
07:17 EDTMDCOThe Medicines Co. downgraded to Market Perform from Outperform at Leerink
Leerink downgraded The Medicines Co. to Market Perform citing uncertainty regarding Angiomax estimates into the appeals trial. The firm lowered its price target for shares to $27 from $30.
News For MDCO From The Last 14 Days
Check below for free stories on MDCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
07:05 EDTMDCOThe Medicines Co. reports Q2 adjusted EPS 31c, may not compare to consensus (2c)
Reports Q2 revenue $183.8M, consensus $183.75M. Reports Q2 unadjusted net loss of (8c).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use